Stay updated on Avelumab Combo Regimens in R/R DLBCL Clinical Trial

Sign up to get notified when there's something new on the Avelumab Combo Regimens in R/R DLBCL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Avelumab Combo Regimens in R/R DLBCL Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The study locations section was expanded to include new sites across the United States (CA, KY, LA, MA, MI, MN, NY), Australia (NSW, Victoria), Belgium, Italy, Poland (Lesser Poland Voivodeship, Lublin Voivodeship), and Korea, and several previously listed locations were removed. This change expands and clarifies where recruitment may take place.
    Difference
    0.9%
    Check dated 2025-12-23T08:37:46.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    Revision updated from v3.3.1 to v3.3.2; no visible changes to study details or page content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-12-01T17:13:04.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Added a note that PubMed publications are automatically filled from PubMed and may not be about the study, and updated the revision tag to v3.3.1. The previous PubMed publication note and revision tag v3.2.0 were removed/updated to reflect the new wording.
    Difference
    0.1%
    Check dated 2025-11-24T14:34:20.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    A notice about a lapse in government funding and NIH operating status was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-17T06:40:04.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Summary
    The study record now shows termination of the trial with closure of arms due to futility and enrollment challenges, citing evolving treatment landscape as the rationale.
    Difference
    0.3%
    Check dated 2025-11-03T01:13:39.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Core content updated to reflect government funding status and a new version (v3.2.0) with added lymphoma resource; previous version (v3.1.0) removed.
    Difference
    2%
    Check dated 2025-10-05T10:12:33.000Z thumbnail image

Stay in the know with updates to Avelumab Combo Regimens in R/R DLBCL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Avelumab Combo Regimens in R/R DLBCL Clinical Trial page.